Originally broadcast: Monday, 20th July 2020
Duration: 60 minutes. Available to watch on demand
How products get highlighted to NICE and how NICE decides which topics to select
How the voluntary pricing scheme affects the likelihood of topic selection and the challenge this creates for NICE
The impact of COVID-19 on appraisals and the plan for the rest of 2020 and 2021
How to influence the process so you can improve the likelihood of getting what you want
What questions relate to horizon scanning and the several things this term actually involves.
Copyright © 2021. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52